首页> 美国卫生研究院文献>The Journal of Headache and Pain >Warfarin as a therapeutic option in the control of chronic cluster headache: a report of threecases
【2h】

Warfarin as a therapeutic option in the control of chronic cluster headache: a report of threecases

机译:华法林作为控制慢性丛集性头痛的治疗选择:三则报告案件

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic cluster headache remains refractory to medical therapy in at least 30% of those who suffer from this condition. The lack of alternative medical therapies that are as effective as, or more effective than, lithium carbonate makes new therapies necessary for this highly disabling condition. Based on a previous report, we gave oral anticoagulants to three patients with chronic cluster headache. Two of them remained cluster headachefree while taking warfarin. In the third patient, the use of warfarin for three weeks initially increased the frequency and intensity of clusterheadache attacks but subsequentlyinduced a prolonged remission. Inspite of the paucity of data available,oral anticoagulation appears tobe a promising therapy for chroniccluster headache.
机译:至少有30%的患有这种疾病的人对慢性丛集性头痛仍然难以接受药物治疗。缺乏与碳酸锂一样有效或更有效的替代医学疗法,使得这种高度致残的疾病需要新的疗法。根据先前的报告,我们对三名慢性丛集性头痛患者进行了口服抗凝剂治疗。他们中的两个在服用华法林的过程中保持丛集性头痛。在第三位患者中,使用华法林三周最初会增加群集的频率和强度头痛发作,但随后导致长期缓解。在尽管缺乏可用数据,口服抗凝似乎对慢性病有希望的疗法丛集性头痛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号